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Direct generation of a homogeneous population of
skeletal myoblasts from human embryonic stem
cells (hESCs) and formation of three-dimensional
contractile structures for disease modeling in vitro
are current challenges in regenerative medicine.
Previous studies reported on the generation of
myoblasts from ESC-derived embryoid bodies (EB),
but not from undifferentiated ESCs, indicating the
requirement for mesodermal transition to promote
skeletal myogenesis. Here, we show that selective
absence of the SWI/SNF component BAF60C (en-
coded by SMARCD3) confers on hESCs resistance
to MyoD-mediated activation of skeletal myogene-
sis. Forced expression of BAF60C enables MyoD to
directly activate skeletal myogenesis in hESCs by in-
structing MyoD positioning and allowing chromatin
remodeling at target genes. BAF60C/MyoD-express-
ing hESCs are epigenetically committed myogenic
progenitors, which bypass the mesodermal require-
ment and, when cultured as floating clusters, give
rise to contractile three-dimensional myospheres
composed of skeletal myotubes. These results iden-
tify BAF60C as a key epigenetic determinant of
hESC commitment to the myogenic lineage and
establish the molecular basis for the generation of
hESC-derived myospheres exploitable for ‘‘disease
in a dish’’ models of muscular physiology and
dysfunction.INTRODUCTION
Generation of tridimensional (3D) structures that recapitulate
histological and functional properties of adult organs and tissues
is a current challenge in regenerative medicine because it
requires abundant and homogeneous population of committed
progenitors from human embryonic stem cells (hESCs). For
instance, formation of hESC-derived contractile 3D skeletalmuscles has never been reported, reflecting the unsuccessful
attempts to directly generate homogeneous populations of skel-
etal muscle progenitors from undifferentiated hESCs. Previous
studies have demonstrated that generation of skeletal myoblasts
could be achieved from embryoid body (EB)-derived meso-
dermal cells (Darabi et al., 2008, 2012; Iacovino et al., 2011) or
from mesenchymal derivatives of ESCs (Barberi et al., 2007;
Goudenege et al., 2012), indicating the requirement for transition
through the mesodermal stage to activate skeletal myogenesis.
This evidence suggests an ‘‘intrinsic’’ resistance to the activation
of the myogenic program in ESCs prior to mesoderm formation.
Indeed, no evidence of direct generation of skeletal muscle
progenitors from undifferentiated hESCs has been reported so
far, raising the question of whether hESCs can be directly re-
programmed into skeletal muscle cells. Direct myogenic conver-
sion of somatic nonmuscle cells upon introduction of MyoD has
provided evidence that a single tissue-specific transcriptional
activator is able to reprogram the nucleus of host cells into the
skeletal muscle phenotype (Weintraub et al., 1989; Gerber
et al., 1997; Chambers and Studer, 2011). However, it is currently
unknown whether ESCs can be reprogrammed into skeletal
myoblasts by ectopic expression of MyoD.
RESULTS AND DISCUSSION
Selective Absence of BAF60C in hESCs Prevents
Activation of Skeletal Myogenesis by Ectopic
Expression of MyoD
We tested the ability of hESCs to undergo direct myogenic
conversion in response to the ectopic expression of MyoD as
compared to human fibroblasts that typically convert into skel-
etal muscle cells upon MyoD expression (Weintraub et al.,
1989). Surprisingly, expression of MyoD in hESCs failed to
activate skeletal myogenesis under the same culture conditions
in which massive myogenic conversion was observed upon
expression ofMyoD inH27 human fibroblasts (Figure 1A and Fig-
ure S1A). Resistance to MyoD-induced myogenic conversion
was observed in different hESC lines tested (H9 and H1) (Fig-
ure S1B). Figure 1A shows that ectopic MyoD was expressed
at comparable levels and was properly localized in the nuclei
of hESCs as well as fibroblasts but failed to activate muscle
gene expression only in hESCs (Figure 1A and Figure S1),Cell Reports 3, 661–670, March 28, 2013 ª2013 The Authors 661
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Figure 1. BAF60C2 Rescues MyoD-Mediated Myogenic Conversion in hESCs
(A) Immunofluorescence staining to detect myosin heavy chain (MHC) (green) and MyoD (red) in human fibroblasts (H27) and hESCs (H9) infected with MyoD or
a control virus (Pgk). Nuclei are visualized by DAPI staining (blue). Cells were cultured in monolayer and induced to differentiate by shifting medium from growing
conditions (growth medium [GM]) to promyogenic differentiation medium (DM). See Experimental Procedures for details.
(B) Relative gene expression of BAF60 subunits (A,B,C) in hESCs (H9), human skeletal myoblasts (husk), and human fibroblasts (H27). Error bars represent ±SD.
(C) Relative gene expression of BAF60 variants and human BAF60C isoforms C1 and C2 were measured at the indicated time points during H9 differentiation
into EBs.
(D) Representative fluorescence staining to detect MHC (red) and Baf60c (green) in human fibroblasts (H27) infected with lentivirus expressing MyoD and in
hESCs (H9) with lentiviruses expressing MyoD alone or together with BAF60C2. After infection, cells were cultured in monolayer and induced to differentiate by
shifting medium from GM to DM.
(E) Efficiency of myogenic conversion was calculated as a percentage of the nuclei contained within the myotubes (n = 3; error bars represent ±SD).
See also Figures S1and S2.suggesting that hESCs might have a ‘‘nuclear landscape’’ not
permissive for activation of themyogenic program.We reasoned
that this could be due to a deficiency in a key component(s) of the
chromatin-modifying machinery that enables MyoD to activate
transcription from target genes. We therefore analyzed the integ-
rity of the chromatin-modifying complexes that are known to
enable MyoD-activated gene expression (de la Serna et al.,662 Cell Reports 3, 661–670, March 28, 2013 ª2013 The Authors2006; Guasconi and Puri, 2009; Sartorelli and Juan, 2011). We
measured by quantitative RT-PCR (qRT-PCR) the expression
levels of key components of these complexes in distinct hESC
lines (H1, H7, and H9) and human H27 fibroblasts and found
that the large majority of them were expressed in all cell lines
analyzed, with the notable exception of the structural sub-
units of the SWI/SNF chromatin remodeling complex, BAF60C
(encoded by SMARCD3), and the alternative SWI/SNF ATPase
BRM (Figure S2). Lack of Baf60c and Brm proteins in mouse
embryonic stem cells was previously observed by Crabtree
and colleagues (Ho et al., 2009). However, while Baf60c is abso-
lutely required for the activation of skeletal myogenesis (Forcales
et al., 2012; Lickert et al., 2004), Brm appears dispensable
(Reyes et al., 1998), with Brg1 being the essential ATPase of
the SWI/SNF complex that remodels the chromatin at MyoD
target genes (Ohkawa et al., 2006; Forcales et al., 2012). Three
alternative variants of the BAF60 subunits—BAF60A, B, and
C—are expressed in somatic cells, with mutually exclusive pres-
ence in distinct SWI/SNF complexes (Debril et al., 2004; Wang
et al., 1996). Of note, while all three variants are expressed in
human skeletal myoblasts and fibroblasts, which are competent
to activate the myogenic program, expression of BAF60A and B,
but not BAF60C, was detected in hESCs, which are resistant
to the activation of the myogenic program (Figure 1B). Interest-
ingly, BAF60C was induced upon EB formation (Figure 1C),
a stage permissive for the activation of skeletal myogenesis
(Iacovino et al., 2011). Two BAF60C isoforms are expressed in
human somatic cells: BAF60C1 and BAF60C2. However, only
BAF60C2 was significantly upregulated during EB formation
(Figure 1C). Thus, we hypothesized that BAF60C2 could be a
limiting factor for the direct activation of the myogenic program
in hESCs and tested whether forced expression of BAF60C2 in
hESCs could restoreMyoD-mediated activation of themyogenic
program. Figures 1D and 1E show that ectopic expression of
BAF60C2 enabled MyoD-directed conversion of hESCs into
myosin heavy chain (MyHC)-positive muscle cells.
Efficient Generation of Skeletal Muscle Cells from
hESCs Requires an Epigenetic Commitment by
BAF60C2 and MyoD, Followed by Activation of Skeletal
Myogenesis within Floating Clusters
Because the efficiency of myogenic conversion in BAF60C2/
MyoD-expressing hESCs was reduced as compared to the
myogenic conversion of MyoD-expressing fibroblasts (Fig-
ure 1E), we considered the possibility that hESCs could receive
optimal differentiation cues from their physiological context; that
is, the network of signals generated by cell aggregation (such
that occurring within EBs) (Keller, 1995). It is well established
that cell-to-cell interactions promote intracellular promyogenic
signaling (Krauss, 2010). To this purpose, we devised a protocol
for generation of skeletal muscle cells from hESCs that included
the transition through an aggregation stage (EB-like clusters)
equivalent to the standard culture conditions that typically
promote EBs from hESCs (see scheme in Figure 2A and Exper-
imental Procedures for details). We generated hESCs (H9 line)
stably expressing BAF60C2 and MyoD (hereby referred to as
hESCBAF60C2/MyoD) and cultured them in conditions permissive
for aggregation into floating clusters for 5 days (pre-EB condi-
tions), followed by dissociation into single cells that were
subsequently exposed to standard myogenic differentiation
medium (post-EB condition; see scheme in Figure 2A). Of note,
we tested various combinations of expression timing of MyoD
andBAF60C2 in different hESC lines and observed the activation
of the myogenic program only when BAF60C2 was expressed
prior to MyoD (data not shown). This protocol led to a dramaticenhancement in the activation of the myogenic program in
hESCBAF60C2/MyoD, with the generation of a homogeneous popu-
lation of committed cells (Figure 2B, pre-EB conditions) that
became competent to activate skeletal myogenesis upon aggre-
gation into EB-like clusters, leading to massive formation of
myogenin/MyHC-positive myotubes after dissociation and ex-
posure to DM conditions (Figures 2B [post-EB conditions] and
2C). Under these conditions, the percentage of myogenic
conversion of hESCBAF60C2/MyoD was much higher (60.1% ±
5% MyHC-positive cells) (Figure 2B) than that observed in stan-
dard conditions for myogenic conversion shown in Figure 1D
(4.67% ± 0.8% MyHC-positive cells). Sporadic formation of
myogenin-positive cells was observed in MyoD-expressing
H9 hESCs (hESCMyoD) cultured in EB medium (Figures 2B and
2C), possibly due to localized upregulation of endogenous
BAF60C2 or to the compensatory activity of BAF60B, as previ-
ously described for cardiomyogenesis (Takeuchi and Bruneau,
2009). However, only hESCBAF60C2/MyoD differentiated into
MyHC-positive myotubes with high efficiency after culture in
EB conditions (60.1% ± 5% MyHC-positive cells from
hESCBAF60C2/MyoD versus 2.5% ± 0.5% from hESCMyoD). Inter-
estingly, forced expression of BAF60C2 alone in hESCs
(hESCBAF60C2) could not activate the skeletal myogenesis in
the absence of MyoD (Figure 2B), indicating that BAF60C2
requires the presence of MyoD to activate muscle gene ex-
pression. These results indicate a multistep progression of
hESCBAF60C2/MyoD through sequential stages of cellular differen-
tiation, including lineage determination by MyoD and BAF60C2
(pre-EB stage) followed by competence to respond to differenti-
ation signals and formation of terminally differentiated myotubes
(post-EB stages). Previous works demonstrated the key role of
BAF60C2 in at least two essential epigenetic events underlying
myogenic differentiation, such asMyoD binding to the chromatin
of target genes and the signal-dependent recruitment of BRG1-
based SWI/SNF chromatin remodeling complex (Forcales et al.,
2012). We used chromatin immunoprecipitation (ChIP) to inves-
tigate the sequential recruitment of MyoD, BAF60C2, and BRG1
to MyoD target genes in hESCBAF60C2/MyoD or hESCMyoD or
control PGK-infected hESCs (hESCPgk) at pre-EB and post-EB
stages. We focused on human MYOGENIN gene, since activa-
tion of MYOGENIN transcription is invariably required for the
execution of the myogenic program during development and
post-natal life (Hasty et al., 1993; Ohkawa et al., 2006). More-
over, the sequential recruitment of MyoD/BAF60C complex,
followed by BRG1-based SWI/SNF complex, has been demon-
strated on myogenin promoter in skeletal myoblasts (Forcales
et al., 2012). In the absence of BAF60C2 (hESCMyoD), MyoD
could not bind theMYOGENIN promoter either in pre-EB condi-
tions or after exposure to the differentiation signals within EB-like
clusters (post-EB conditions) (Figure 2D). Forced expression of
BAF60C2 (hESCBAF60C2/MyoD) enabled MyoD recruitment to
MYOGENIN promoter together with BAF60C2, but not BRG1,
in pre-EB conditions (Figure 2D). Formaldehyde-assisted isola-
tion of regulatory elements (FAIRE) showed that BAF60C2 and
MyoD binding to MYOGENIN promoter correlated with incipient
chromatin accessibility in correspondence of the PBX binding
site (Berkes et al., 2004) in hESCBAF60C2/MyoD as compared
to control lines in pre-EB conditions (Figure 2E). This evidenceCell Reports 3, 661–670, March 28, 2013 ª2013 The Authors 663
Figure 2. Efficient Generation of Muscle Cells from hESCBAF60c2/MyoD Is Achieved through BAF60C-Dependent Chromatin Targeting ofMyoD
prior to Differentiation into EBs
(A) Protocol to derive muscle cells from undifferentiated hESCs (H9) infected sequentially with BAF60C2 (B) andMyoD (M) lentiviruses. Cells were collected at the
pre-EB or post-EB stages, as indicated, for further analysis.
(B) Representative images of hESCs infected with control (Pgk), BAF60C2-IRESGFP, MyoD, and BAF60C2/MyoD lentiviruses. Pre-EB cells were stained with
antibodies against MyoD and green fluorescent protein to reveal exogenous proteins. Post-EB cells were stained for MHC and myogenin (Myog) to monitor the
myogenic conversion.
(C) qRT-PCR analysis performed at pre- and post-EB stage. Error bars represent ±SD.
(D) ChIP analysis onMYOGENIN promoter and NKX2.5 enhancer. Chromatin from Pgk, M, and BM cells at pre-EB and post-EB stages was immunoprecipitated
with antibodies against MyoD, Baf60c, and Brg1, and IgG was used as a control. Protein recruitment is expressed as relative enrichment of each factor (black
bars) compared to IgG (white bars) after normalization for total input control (n = 3; error bars represent SEM).
(E) FAIRE assay performed in pre- and post-EB cells to assess chromatin status onMYOGENIN promoter and NKX2.5 enhancer. A representative experiment is
shown (n = 3). Primer amplicons are depicted.
(F) Recruitment of Pol II ser5P and Pol II ser2P on MYOGENIN promoter or coding region performed on pre-EB and post-EB cells as described in (D).
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indicates an instructive role of BAF60C2 in the early recognition
of MyoD target sequences. Moreover, only in hESCBAF60C2/MyoD
BRG1 recruitment to MYOGENIN promoter was detected in
response to differentiation signals (post-EB conditions) (Fig-
ure 2D). The recruitment of BRG1-based SWI/SNF complex
correlated with a dramatic enhancement in chromatin accessi-
bility that was extended to the MEF2/Ebox sites (Figure 2E)
and the engagement of the elongation-competent (serine 2
phosphorylated) form of polymerase II (Pol II ser2P) (Figure 2F),
leading to activation of transcription (Figure 2C). Interestingly,
serine 5 phosphorylated Pol II (Pol II ser5P) was detected at
the transcription start site of MYOGENIN promoter in hESCs
regardless the presence of MyoD and/or BAF60C2 (Figure 2F),
according to the ‘‘poised’’ conformation of the chromatin at
tissue-specific genes previously described in ESCs (Azuara
et al., 2006; Boyer et al., 2006; Lee et al., 2006; Mikkelsen
et al., 2007). Of note, BAF60C2 and BRG1 were not detected
on the enhancer of the cardiac-specific gene NKX2.5 in
hESCBAF60C2/MyoD (Figure 2D). NKX2.5 is induced by BAF60C2
and the transcriptional activators GATA4 and TBX5 in cardiac
progenitors (Lickert et al., 2004; Takeuchi and Bruneau,
2009) and was expressed in control hESCPgk and hESCMyoD,
but not in hESCBAF60C2/MyoD (see Figure 3A). Consistently,
NKX2.5 enhancer showed a closed chromatin conformation in
hESCBAF60C2/MyoD, while in hESCPgk and hESCMyoD an increased
accessibility was detected at GATA4 binding sites (Figure 2E).
This evidence further supports the conclusion that BAF60C2
enables selective activation of skeletal muscle genes by MyoD.
The sequential and dynamic chromatin modifications shown in
Figures 2D–2F define two distinct stages that reflect a ‘‘silent’’
epigenetic commitment to the myogenic lineage (pre-EB condi-
tions) followed by the transcriptional activation of muscle genes
in post-EB conditions.
Ectopic Expression of BAF60C2/MyoD Bypasses the
Requirement for Mesodermal Transition to Promote
Skeletal Myogenesis in hESCs
The direct activation of muscle gene expression by MyoD in
hESCBAF60C2/MyoD is consistent with the nuclear reprogramming
toward the skeletal muscle lineage, which is typically accompa-
nied by the silencing of pluripotency genes and repressing
alternative cell fates. Indeed, pluripotency genes were readily
repressed in hESCs upon MyoD and BAF60C2 expression
(data not shown), likely reflecting the functional antagonism
between tissue-specific transcriptional activators and pluripo-
tency. Similarly, markers of the alternative lineages within the
three germ layers were repressed in hESCBAF60C2/MyoD as com-
pared to hESCPgk (Figure 3A). Most of these markers showed
a peak of expression between days 3 and 5 in hESCPgk-derived
EBs but not in hESCBAF60C2/MyoD-derived EBs (Figure 3A). Inter-
estingly, while the expression pattern of many of these genes
was partly overlapping in hESCMyoD- and hESCBAF60C2/MyoD-
derived EB-like clusters during the first days of cultures in EB
conditions, a late increase (between days 4 and 5) in the expres-
sion of lineage-specific markers, such as NKX2.5, CERBERUS1,
and NESTIN, was observed in hESCMyoD-derived aggregates
(Figure 3A). This might reflect that ability of MyoD to repress plu-
ripotency (Watanabe et al., 2011) via a BAF60C2-independentmechanism that leads to spontaneous commitment to various
lineages by default (S.A. and P.L.P., unpublished data).
Importantly, primitive markers of mesoderm (BRACHYURY T,
MESOGENIN, and MESP1) were specifically repressed in
hESCBAF60C2/MyoD-derived EBs (Figure 3A). The only meso-
dermal gene that showed an earlier and more robust pattern of
expression in hESCBAF60C2/MyoD-derived EB-like clusters, as
compared to hESCPgk- and hESCMyoD-derived clusters, was
the skeletal muscle progenitor marker PAX3, which estab-
lishes the myogenic identity within the paraxial mesoderm
(Buckingham and Relaix, 2007) (Figure 3A). This is consistent
with the selective activation of the skeletal muscle program in
hESCBAF60C2/MyoD. Figure 3B shows that hESCBAF60C2/MyoD-
derived EBs uniformly express PAX3 (78.5% ± 6%), while the
primitive mesoderm marker BRACHYURY T could not be de-
tected. By contrast, PAX3-positive cells were detected at
much lower frequency in hESCPgk- and hESCMyoD-derived EB-
like clusters (10.0% ± 2.4% and 22.2% ± 3%, respectively),
most of which coexpressed BRACHYURY T (Figure 3B), possibly
reflecting the myogenic commitment of a subset of mesodermal
derivatives. Thus, BAF60C2 and MyoD appear to generate
an ‘‘epigenetic landscape’’ that imposes the selective activation
of muscle gene expression in hESCs, leading to their direct
conversion into skeletal myoblasts without the transition
through the mesodermal stage. This evidence is well supported
by the recruitment of BAF60C2 and BRG1 and activation of
the MYOGENIN promoter, but not the NKX2.5 enhancer, in
hESCBAF60C2/MyoD (Figures 2D–2F).
To further demonstrate the homogeneous composition of
hESCBAF60C2/MyoD by skeletal muscle progenitors, we dissoci-
ated hESCBAF60C2/MyoD-derived EB-like clusters (as compared
to the equivalent population from hESCPgk and hESCMyoD) and
sorted them by fluorescence-activated cell sorting (FACS) using
the surface marker CD56 (NCAM1), which has previously been
used to isolate human skeletal myoblasts (Zheng et al., 2007).
Surprisingly, we found that the large majority of cells from disso-
ciated hESCBAF60C2/MyoD-derived floating aggregates, as well as
hESCPgk and hESCMyoD, were NCAM1 positive. This result
reveals that NCAM1 expression cannot define by itself a popula-
tion of skeletal muscle progenitors from hESCs and indicates
that NCAM1 is probably expressed in cells undergoing transition
toward a variety of lineages (Evseenko et al., 2010). However,
when we measured the relative expression levels of NCAM1 in
our hESC populations as compared to those of human primary
skeletal myoblasts (HSkM), we found that hESCBAF60C2/MyoD
were enriched in cells with expression levels (73%) of NCAM1
that were higher than those of hESCPgk (22%) and hESCMyoD
(54%) and similar to those detected in HSkM (data not shown).
We therefore gated the high NCAM1-expressing cells among
the population of NCAM1-positive FACS hESCs (Figure 3C)
and measured their myogenic potential in vitro as percentage
of myogenin/MyHC double-positive multinucleated cells formed
among the same number of cells cultured in differentiation
medium (Figure 3D). Figure 3D shows that the high NCAM-posi-
tive cells sorted from hESCBAF60C2/MyoD-derived EB-like clusters
evenly differentiated in myogenin/MYHC double-positive multi-
nucleated myotubes (81.7% ± 3%), while only a minority of cells
from hESCMyoD-derived aggregates (4.3% ± 0.7%) and none ofCell Reports 3, 661–670, March 28, 2013 ª2013 The Authors 665
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Figure 3. Direct Generation of Myogenic Progenitors from hESCBAF60C2/MyoD
(A) hESCs H9 infected with control (Pgk), MyoD (M), or BAF60C2+MyoD (BM) were collected for 5 consecutive days from the onset of differentiation into EB-like
clusters and analyzed by qRT-PCR to monitor the expression of genes indicative of the three germ layers (mesoderm, endoderm, ectoderm). Values are ex-
pressed as relative to Pgk day 0. Error bars represent SEM (n = 3).
(B) EB-like clusters at day 4 (d4) were stained for early precursormarkers BRACHYURY T and PAX3. Scale bars are 50 mm. Insets show the highermagnification of
nuclear staining for the indicated proteins.
(C and D) Isolation and characterization of CD56pos (expressing high levels of CD56) population sorted from day 5 aggregates derived from hESCs infected with
Pgk, MyoD, or BAF60C2/MyoD. Histogram plots show the specific staining signal (Pgk, M, BM) versus unstained signal (unst) and the percentage of cells ex-
pressing CD56 (NCAM) (C). CD56pos cells were induced to differentiate and analyzed for the expression of skeletal muscle proteins myogenin and MHC by
immunofluorescence (D).
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Figure 4. Generation of Skeletal Myospheres from hESCBAF60C2/MyoD and Electrophysiological Properties
(A) Schematic representation of the protocol used to generate 3D-skeletal myospheres.
(B) hESCs cultured in EB conditions to generate EBs according to the protocol depicted in (A) were subsequently sectioned and stained for the indicated muscle
markers.
(C) Percentage ofMYOG/MHC-positive cells within single EBs. EBswere classified based on the enrichment ofmyogenic fibers as follows: nomyofibers (), up to
10% (+), up to 30% (++), up to 100% (+++).
(D) Representative profile of gene expression of myogenic markers such asMYOG, embryonic MYHC (MYH3), perinatal MYHC (MYH8),MYOD1, and the cardiac
marker GATA4. Values are expressed as relative to Pgk day 0 (bars represent SD).
(E) Snapshot from Movie S1 showing contraction of myospheres.
(F) Representative calcium transient recordings in hESC-derived cardiomyocytes (CM, black line), human skeletal myotubes derived from human fibroblasts
converted by MyoD (SkM, blue line), and hESCBAF60C2/MyoD-derived myospheres (red line).
(G) Snapshot from Movie S2 showing the local calcium distribution inside skeletal muscle cells.
(H) Scheme of the three-step generation of myospheres form hESCBAF60C2/MyoD.
See also Figure S3.the cells from hESCPgk-derived bodies could differentiate into
myotubes under the same conditions. This result demonstrates
that hESCBAF60C2/MyoD-derived EB-like clusters are composed
of a homogeneous population of skeletal myoblasts that retain
the ability to differentiate into skeletal myotubes.
Generation of Contractile Myospheres from
hESCBAF60C2/MyoD
We therefore hypothesized that such a homogeneous population
of hESC-derived myoblasts could bias the composition of EB-like clusters toward the formation of 3D contractile structures en-
riched in skeletal myofibers (skeletal myospheres). We devised
a specific protocol by culturing hESCBAF60C2/MyoD (or hESCPgk
and hESCMyoD) in EB medium for 5 days, followed by the expo-
sure of derived EB-like clusters to myogenic differentiation
medium for additional 14 days (see scheme in Figure 4A). This
protocol differs from the one shown in Figure 2A because it
does not include dissociation of floating EB-like clusters and is
therefore permissive for the formation of 3D structures. Only
hESCBAF60C2/MyoD gave rise to EB-like structures that were fullyCell Reports 3, 661–670, March 28, 2013 ª2013 The Authors 667
enriched in myogenin/MyHC-positive myofibers (Figures 4B and
4C) and expressed typical skeletal muscle markers, such as
myogenin, MyH3, and MyH8, but not cardiac-specific genes,
such as GATA4 (Figure 4D). hESCMyoD-derived EBs showed
rare areas, rather than diffuse formation, of myogenin/MYHC-
positive cells (Figures 4B and 4C), possibly reflecting localized
concentrations of EB-derived signals, such as morphogenes,
that might induce endogenous BAF60C2 expression in MyoD-
expressing cells. Importantly, hESCBAF60C2/MyoD-derived EB-
like structures underwent spontaneous contraction at very
high frequency, as it was detected in about 20% of the EBs
during 60 s observation of each plate (Movie S1 [snapshot in Fig-
ure 4E]; Figure S3A). We therefore defined them as contractile
‘‘myospheres.’’ Dissociation of hESCBAF60C2/MyoD-derived myo-
spheres resulted in the formation of myogenin/MyHC-positive
myofibers (Figure S3B). We investigated the contractile activity
of hESCBAF60c2/MyoD-derived myospheres. We used dynamic
distribution of the cytosolic calcium in live cells to discriminate
skeletal muscle-type contraction from cardiac-type contraction
behavior. Figure 4F and Movie S2 (snapshot in Figure 4G)
show that hESCBAF60c2/MyoD-derived myospheres are exhibiting
the slow-rising long-lasting increase in local calcium concentra-
tion typical of skeletal muscle-type calcium artifacts (Capes
et al., 2011). Individual fluorescent Fluo-4 signals from either
intact myospheres derived from hESCBAF60C2/MyoD or dissoci-
ated cells from myospheres during 20 s recordings show intra-
cellular calcium dynamics typically reflecting skeletal muscle
contractions (Figure 4F, compare blue and red lines) that are
clearly distinguished from cardiac contraction contractions
(Figure 4F, black line; see also Movie S2). The finding that
hESCBAF60C2/MyoD-derived myospheres, either intact or dissoci-
ated, showed a pattern of calcium transient similar to control
skeletal myotubes demonstrates that the vast majority of con-
tracting cells in hESCBAF60c2/MyoD-derived myospheres exhibit
skeletal muscle contractile activity (Figures 4F and 4G). This
evidence, together with the lack of activation (Figure 2) and
expression (Figures 3 and 4) of cardiac markers, conclusively
demonstrates that BAF60C2 and MyoD are sufficient to convert
hESCs into a homogeneous population of committed myoblasts
that, when cultured in EB conditions, generate 3D contractile
myospheres. These data emphasize the importance of imposing
an epigenetic landscape that commits hESCs to myogenic
progenitors and makes them competent to respond to the
signals derived from EB-like structures (myobodies), ultimately
leading to the formation of spontaneously contracting myo-
spheres (Figure 4H).
Collectively, these data demonstrate that the requirement for
transition through the mesodermal stage to activate myogenesis
in hESCs can be bypassed by forced expression of BAF60C2
and MyoD. The identification of BAF60C2 as a limiting factor
for the epigenetic reprogramming of hESCs to the myogenic
lineage is of particular relevance because it provides the molec-
ular explanation of the previously reported requirement of
mesodermal transition to activate skeletal myogenesis in ESCs
(Darabi et al., 2008, 2012; Iacovino et al., 2011). The evidence
that BAF60C2 instructs tissue-specific transcriptional activators
(such as MyoD) to activate lineage-specific gene expression
suggests that repression of BAF60C2 in undifferentiated hESCs668 Cell Reports 3, 661–670, March 28, 2013 ª2013 The Authorsis a necessary event to maintain pluripotency, presumably to
prevent the formation of an epigenetic landscape permissive
for commitment to the myogenic lineage. Along this line, we
speculate that BAF60C2 derepression in hEBs (mimicked in
our experimental conditions by hESCBAF60c2/MyoD) might confer
on hESCs the competence to properly respond to complex intra-
cellular events elicited by external signals (e.g., activation of p38
and AKT pathways) (Serra et al., 2007) and developmental cues,
such as TGFbeta-SMAD2/3 signaling (Capes et al., 2011) that
enable MyoD to activate muscle gene expression. Overall, the
ability to epigenetically reprogram hESCs into a homogenous
population of skeletal muscle progenitors that can generate 3D
contractile myospheres provides an unprecedented opportunity
to establish ‘‘in dish’’ models of study of skeletal muscle physi-
ology and mechanism of diseases.
EXPERIMENTAL PROCEDURES
hESC Culture
Undifferentiated hESCs, H9 and H1 (passages 35–45), were cultured and
manipulated as indicated in Extended Experimental Procedures.
Intracellular Calcium Recording Assays in Living Cells
Calcium-transient hESC cell clusters were recorded using the IC100 High
Content Imaging system equipped with the KIC (Kinetic Image Cytometer)
electrical field stimulation module. For labeling and recording, see Extended
Experimental Procedures.
Immunofluorescence and Immunocytochemical Analysis
See Extended Experimental Procedures for the details and antibody used. EBs
were prepared according the protocol described in Gomes et al. (2010).
Gene Expression Analysis
Total RNA was isolated with TRIzol and retrotranscribed using reverse tran-
scription reagent (Applied Biosystems). qRT-PCR was performed according
the manufacturer’s instructions on Mx3000P (Stratagene) using SYBR Green
Master Mix. Data were normalized to the expression of GAPDH gene (for
SYBR Green) and relative quantification was calculated by the Comparative
Ct method. Primers used are listed in Table S1.
FAIRE
Chromatin for FAIRE (formaldehyde-assisted isolation of regulatory elements)
analysis was prepared as previously described in Simon et al. (2012). A total of
10 ng of FAIRE purified DNA or 10 ng of purified input DNA was analyzed by
qRT-PCR. The signal of FAIRE-purified chromatin is presented as a fraction
of input-purified chromatin. See details in Extended Experimental Procedures.
Primers used are listed in Table S1.
ChIP Assay
ChIP was performed as described in Forcales et al. (2012) with some modifi-
cations (see Extended Experimental Procedures for details). Chromatin
extracts were immunoprecipitated overnight on rotating platform at 4C with
the following antibodies: anti-MyoD (Santa Cruz, sc-760) anti-Brg1 (Santa
Cruz, sc-17796X), custom-made anti-BAF60c antibody, anti-Pol II ser5P
(39233, activemotif) and anti-Pol II ser2P (Abcam, ab24758) with immunoglob-
ulin (Ig) G-IgM linker antibody (Abcam, ab9175) or normal IgG as control.
Primers used are listed in Table S1.
Statistical Analysis
Data are presented as mean ± SEM unless otherwise indicated. Differences
between groups were analyzed for statistical significance using unpaired the
Student’s t test with significance being defined as *p < 0.05, **p < 0.01, or
***p < 0.001.
SUPPLEMENTAL INFORMATION
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figures, one table, and two movies and can be found with this article online at
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